massarray designer software version 4 0 (agena bioscience)
agena bioscience is a verified supplier 
agena bioscience manufactures this product 
97
Structured Review
agena bioscience
massarray designer software version 4 0
Massarray Designer Software Version 4 0, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 19726 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+analyzer+4+0/MassARRAY+Nanodispenser+Samsung+LT/10__52635_slash_eamr_slash_16__1__28___39-84-10-15
Average 97 stars, based on 19726 article reviews
Massarray Designer Software Version 4 0, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 19726 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/massarray+analyzer+4+0/MassARRAY+Nanodispenser+Samsung+LT/10__52635_slash_eamr_slash_16__1__28___39-84-10-15
Average 97 stars, based on 19726 article reviews
massarray designer software version 4 0 - by Bioz Stars,
2026-11
97/100 stars
Images
Related Articles
Purification:Article Title: Epigenetic modification facilitates proline synthase PYCR1 aberrant expression in gastric cancer. Article Snippet: Background & aims: Pyrroline-5-carboxylate reductase 1 (PYCR1) upregulation contributes to the progression of gastric cancer (GC) and indicates poor survival.. However, PYCR1 expression profile in GC subtypes and the mechanism behind its upregulation are not well-studied.. Methods: PYCR1 expression profiles in GC subtypes and different stages of gastric carcinogenesis were assessed in different GC cohorts. Article Title: Association of BMAL1 and CLOCK Gene Polymorphisms with Preeclampsia Risk with Subtype Analysis Article Snippet: .. The final extension products were purified, spotted onto a SpectroCHIP ® bioarray (Agena Bioscience, San Diego, CA, USA), and subjected to MALDI-TOF MS analysis on a Multiplex Assay:Article Title: MassARRAY-based targeted detection of SLC22A5 mutations: A feasibility study for secondary screening of primary carnitine deficiency in newborns. Article Snippet: This study aimed to evaluate the feasibility of using MassARRAY molecular mass spectrometry to detect SLC22A5 gene mutations in second-tier screening for primary carnitine deficiency (PCD) among newborns.. The goal is to provide technical evidence to support improvements in PCD screening and to reduce diagnostic delays.. We first reviewed literature and databases to identify commonly reported pathogenic variants in the SLC22A5 gene among the Chinese population and established a hotspot mutation panel. Polymerase Chain Reaction:Article Title: MassARRAY-based targeted detection of SLC22A5 mutations: A feasibility study for secondary screening of primary carnitine deficiency in newborns. Article Snippet: This study aimed to evaluate the feasibility of using MassARRAY molecular mass spectrometry to detect SLC22A5 gene mutations in second-tier screening for primary carnitine deficiency (PCD) among newborns.. The goal is to provide technical evidence to support improvements in PCD screening and to reduce diagnostic delays.. We first reviewed literature and databases to identify commonly reported pathogenic variants in the SLC22A5 gene among the Chinese population and established a hotspot mutation panel. Article Title: Distribution Characteristics and Impacting Factors of Drug CYP Enzymes and Transporters in the Gastrointestinal Tract of Chinese Healthy Subjects. Article Snippet: The abundance of drug metabolic enzymes (DMEs) and transporters (DTs) in the human gastrointestinal tract significantly affects xenobiotic exposure in the circulating system, the basis of these compounds acting on humans.. However, accurately predicting individual exposure in healthy subjects remains challenging due to limited data on protein levels throughout the gastrointestinal tract within the same individuals and inadequate assessment of factors influencing these levels.. Therefore, we conducted a clinical study to obtain biopsy samples from 8 different gastrointestinal segments in 24 healthy Chinese volunteers. Amplification:Article Title: MassARRAY-based targeted detection of SLC22A5 mutations: A feasibility study for secondary screening of primary carnitine deficiency in newborns. Article Snippet: This study aimed to evaluate the feasibility of using MassARRAY molecular mass spectrometry to detect SLC22A5 gene mutations in second-tier screening for primary carnitine deficiency (PCD) among newborns.. The goal is to provide technical evidence to support improvements in PCD screening and to reduce diagnostic delays.. We first reviewed literature and databases to identify commonly reported pathogenic variants in the SLC22A5 gene among the Chinese population and established a hotspot mutation panel. Article Title: Distribution Characteristics and Impacting Factors of Drug CYP Enzymes and Transporters in the Gastrointestinal Tract of Chinese Healthy Subjects. Article Snippet: The abundance of drug metabolic enzymes (DMEs) and transporters (DTs) in the human gastrointestinal tract significantly affects xenobiotic exposure in the circulating system, the basis of these compounds acting on humans.. However, accurately predicting individual exposure in healthy subjects remains challenging due to limited data on protein levels throughout the gastrointestinal tract within the same individuals and inadequate assessment of factors influencing these levels.. Therefore, we conducted a clinical study to obtain biopsy samples from 8 different gastrointestinal segments in 24 healthy Chinese volunteers. other:Article Title: Association of BMAL1 and CLOCK Gene Polymorphisms with Preeclampsia Risk with Subtype Analysis. Article Snippet: Genotype calls were automatically assigned by the Mass Spectrometry:Article Title: Distribution Characteristics and Impacting Factors of Drug CYP Enzymes and Transporters in the Gastrointestinal Tract of Chinese Healthy Subjects. Article Snippet: The abundance of drug metabolic enzymes (DMEs) and transporters (DTs) in the human gastrointestinal tract significantly affects xenobiotic exposure in the circulating system, the basis of these compounds acting on humans.. However, accurately predicting individual exposure in healthy subjects remains challenging due to limited data on protein levels throughout the gastrointestinal tract within the same individuals and inadequate assessment of factors influencing these levels.. Therefore, we conducted a clinical study to obtain biopsy samples from 8 different gastrointestinal segments in 24 healthy Chinese volunteers. Software:Article Title: Characterization of DNA Methylation Episignatures for Radon-Induced Lung Cancer Article Snippet: After resin purification, products were transferred to the SpectroCHIP matrix chip (Agena, San Diego, CA, USA). .. Post-sampling, the chip was analyzed by the |